Picture of Cellectar Biosciences logo

CLRB Cellectar Biosciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual cashflow statement for Cellectar Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-13.6-13.2-14.1-15.1-24.1
Depreciation
Non-Cash Items0.7372.280.880.3491.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.259-0.5691.390.6710.199
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities-11-11.4-11.7-13.9-22.6
Capital Expenditures-0.347-0.385-0.025-0.062-0.141
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0550
Sale of Fixed Assets
Cash from Investing Activities-0.347-0.33-0.025-0.062-0.141
Financing Cash Flow Items-0.116-0.0010
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9.93159.0260.51.25
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.443.25-2.746.6-21.5

Or unlock with your email

Or unlock with your email